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Background: Hypersensitivity pneumonitis (HP) is an inter-
stitial lung disease that develops following repeated ex-
posure to inhaled particulate antigens. The family of Fcγ  re-
ceptors (FcγRs) has emerged as central regulators for mod-
ulating both pro-and anti-inflammatory responses. However, 
the role of FcγRs in the development of HP has not been in-
vestigated yet. Methods: To explore the functional roles of 
FcγRs in HP, FcγR
−/− and B6 mice were challenged with 
Saccharopolyspora rectivirgula (SR) antigen intranasally, 
and compared these mice in terms of the histological change, 
infiltrated immune cells in BALF and in vitro immune 
responses. Results: FcγR
−/− mice exhibited attenuation of 
HP in terms of histological alterations, and reduced numbers 
of neutrophils and macrophages in and the increased 
CD4：CD8 ratio of bronchoalveolar lavage fluid. The lungs 
of FcγR
−/− mice showed high production of Th2 cytokine 
such as IL-4 and slightly low production of Th1 cytokine, 
INF-γ  compared to those of B6 mice. However, SR-specific 
adaptive immune responses of FcγR
−/− mice were similar 
to those of B6 mice. Conclusion: These results demonstrate 
that activating Fcγ receptors play an important role in acti-
vating neutrophils and macrophages in pulmonary in-
flammation and inducing Th1 differentiation by regulating cy-
tokine expression in SR-induced HP.
[Immune Network 2010;10(1):26-34]
INTRODUCTION
Hypersensitivity pneumonitis (HP) is a group of lung diseases 
that result from repeated pulmonary exposure to a variety of 
environmental organic dusts, fungi, and molds with uncertain 
immunological mechanisms (1). This disorder affects the pa-
renchyma  and  the  small  airways  of  the  lungs  and  presents 
an acute, subacute or chronic form. Consequently, HP may 
lead to irreversible pulmonary damages, which cause fibrosis 
or emphysema, and depend on several factors such as dura-
tion  of  exposure  and  nature  of  the  inhaled  antigens  (2).
    Although  the  pathogenesis  of  HP  is  incompletely  under-
stood, it has been generally accepted that a combination of 
humoral and cell-mediated immune responses contributes to 
the development of HP (3). Several studies have suggested 
that the murine models of experimental HP are mediated by 
Th1  immune  responses.  In  mice,  adoptive  transfer  of  Th1 
clones increased cell infiltration and caused reversible HP (4). 
Moreover, when the Th1/Th2 balance shifts toward Th1 im-
mune responses, the HP is more severe whereas it is attenu-
ated  by Th2-biased responses (5,6). Beside T  cells, various 
immune cell types including neutrophils, lymphocytes, mono-
cytes, and macrophages have been known to be involved in 
the development of HP (7). Upon antigen challenge, a large 
number of alveolar macrophages infiltrate the lungs and se-
crete cytokines and chemokines such as TNF-α, IL-1, IL-8, 
and  MIP-1α,  which  recruit  neutrophils  and  lymphocytes Fcγ Receptors Modulate Murine Hypersensitivity Pneumonitis
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(8,9). Chemokine-induced infiltration of neutrophils is found 
in the alveoli and followed by an influx of activated T cells 
with a predominance of CD8
＋ T cells (8). In Saccharopoly-
spora  rectivirgula ( S R ) - i n d u c e d  H P  o f  m u r i n e  m o d e l s ,  n e u -
trophils are most prominent in bronchoalveolar lavage fluid 
(BALF) immediately after antigen challenge, and they produce 
a large amount of IFN-γ (10). Moreover, we previously dem-
onstrated  that  NKT  cells  suppress  IFN-γ-producing  Gr-1
＋ 
granulocytes by producing IL-4, resulting  in the attenuation 
of SR-induced HP (11). These observations suggest that mac-
rophages, neutrophils and NKT cells may play an important 
role  in  development  of  HP.
  F c γ receptors (FcγRs) for IgG are surface glycoproteins 
and  bridge  humoral  and  cellular  immunity  by  directing  the 
interaction of antibodies with effector cells. These receptors 
are expressed on effector cells of the immune system and me-
diate  phagocytosis,  antibody-dependent  cell-mediated  cyto-
toxicity (ADCC), and activation of inflammatory cells (12,13). 
To date, four different classes of FcγRs (FcγRI, FcγRIIB, 
FcγRIII  and  FcγRIV)  have  been  recognized  in  mice  (14, 
15). FcγRIIB provides inhibitory signals, whereas FcγRI, Fc
γRIII,  and  FcγRIV  act  as  activating  receptors  in  immune 
cells (16). In mice, monocytes and macrophages express all 
activating and inhibitory FcγRs (FcγRI-FcγRIV), while neu-
trophils express the inhibitory FcγRIIB and the activating Fc
γR I I I  a n d  F cγRIV.  In  addition,  the  expression  of  FcγRI, 
FcγRIIB,  and  FcγRIII  dominates  on  dendritic  cell  (DC)s 
(17).  In  rodents,  cell  surface  expression  and  signaling  ca-
pacity  of  all  activating  FcγRs  (FcγRI,  FcγRIII,  and  Fcγ
RIV) are dependent on the γ-chain. Therefore, genetic dele-
t io n o f th is  s ub u ni t le ad s t o lo ss  o f c el l su rfa ce  ex p re ssi on 
of FcγRs, resulting in functional deficiency of these activat-
ing FcγRs. Therefore, γ-chain of Fc receptor-knockout ani-
mals showed dramatically impaired antibody mediated effec-
tor  cell  responses  (14,18-21).
    During HP, immune complexes formed by soluble antigens 
and IgG antibodies trigger the complement cascade, resulting 
i n  a c t i v a t i o n  o f  a l v e o l a r  m a c r o p h a g e ,  i n  s e q u e n c e ,  r e c r u i t -
ment of neutrophils and lymphocytes (2). Furthermore, prom-
inent  humoral  responses  have  been  reported  in  pigeon 
fancier's disease, one of the most common HP in human (22), 
as revealed by the elevated levels of IgGs in BALF and the 
infiltration  of  B  lymphocytes  into  interstitial  and  alveolar 
spaces  (23,24).  Based  on  these  observations,  we  postulate 
that immune complexes of exposed antigens and IgGs acti-
vate  neutrophils  and  macrophages  via  FcγRs,  which  may 
contribute to initiation of pulmonary inflammation upon SR 
antigen  challenge.  Therefore,  in  this  study,  we  investigated 
the functional roles of FcγRs in the development of murine 
SR-induced  HP  using  Fcγ-chain  knockout  mice.
MATERIALS AND METHODS
Mice
C57BL/6  (B6)  mice  were  purchased  from  Orient  Company 
(Seoul,  Korea)  and  FcγR
−/− m i c e  w e r e  p u r c h a s e d  f r o m  
Taconic (Germantown, NY). The mice were maintained in a 
specific pathogen-free environment at the AAALAC accredited 
the  Clinical  Research  Institute  of  Seoul  National  University 
Hospital. All procedures involving animals were approved by 
the  Institutional  Animal  Care  and  Use  Committee  of  the 
Clinical  Research  Institute  of  Seoul  National  University 
Hospital.
Antigens
SR antigen was prepared from a strain of SR obtained from 
the  American  Type  Culture  Collection  (ATCC,  catalog  no. 
29034, Manassas, VA), which was grown in a lysogeny broth 
(LB) in a 55
oC shaking incubator for 4 days, centrifuged, and 
rinsed with PBS three times. Next, SR antigen was homogen-
ized and lyophilized. The SR antigen was re-suspended in py-
rogen-free saline. SR antigen contained less than 20 ng/mg 
endotoxin, estimated using a limulus amebocyte lysate assay 
( S i g m a  C h e m i c a l ,  S t .  L o u i s ,  M O ) .
The induction of HP and histological examination of 
the lungs
HP was induced by intranasal administration of 150μg SR an-
tigen  in  saline  into  mice  under  light  anesthesia  using 
isoflurane.  The  procedure  was  performed  on  three  consec-
utive days in each week for three weeks. To evaluate histo-
logical alteration of the lungs, paraffin sections of the lungs 
fixed in formalin were cut and stained with hematoxylin and 
eosin. Pathologic scores were defined as follows: 0, no lung 
abnormality;  1∼5,  the  presence  of  inflammation  and  gran-
ulomas involving 10, 10∼30, 30∼50, 50∼80, and ＞80% of 
the  lungs,  respectively.
Bronchoalveolar lavage and FACS analysis
To  preparation  BALF  from  mice,  tracheas  were  cannulated 
and lungs were lavaged five times with 1ml of cold PBS. Each 
sample was then centrifuged at 2,000 rpm for 10 min at 4
oC. Fcγ Receptors Modulate Murine Hypersensitivity Pneumonitis
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The total number of cells was counted by a hemacytometer, 
and the samples were incubated with mAbs for 5 min on ice 
to  block  FcγR I I / I I I .  W i t h o u t  w a s h i n g ,  t h e s e  c e l l s  w e r e  
stained in a 200μl total volume with a 1μg combination of 
the  following  mAbs:  anti-CD8,  CD4,  TCR,  B220,  F4/80, 
NK1.1,  CD11c,  CD11b,  and  Gr-1  mAbs.  These  mAbs  were 
purchased from BD bioscience (SanDiego, CA) or Ebioscience 
(San diego, CA). Data were acquired by FACS Calibar (Becton 
D i c k i n s o n ,  S a n  J o s e ,  C A ,  U S A ) .
ELISA for measurement of SR-specific IgGs
Diluted  serum  (1：10)  was  added  to  ELISA  high-binding 
plates (Greiner, USA Scientific, Inc., Ocala, FL) coated with 
SR (500μg/ml) antigen in PBS (pH 7.4) and incubated over-
night at 4
oC. Next, alkaline phosphatase-conjugated goat an-
ti-mouse IgG (Pierce, Rockford, IL) diluted in PBS/0.1% bo-
v i n e  s e r u m  a l b u m i n  ( B S A )  ( 1 ：5,000)  was  added  and  the 
plates  were  incubated  for  1  h  at  room  temperature.  The 
plates were then washed and 100μl of phosphatase substrate 
(ρ-nitrophenyl-phosphate in a carbonate buffer, pH 9.6) was 
added to each well. The absorbance of each sample was read 
at 405 nm using a BioTek ELx808 microplate reader and Gen5 
software package (BioTek Instruments Inc., Winooski, VT).
SR-specific proliferation assay
The spleen cells were taken from B6 and FcγR
−/− mice ad-
ministered SR antigen for 3 weeks and cultured with filtered 
SR  antigen.  SR-specific  immune  cell  proliferation  was  de-
t e r m i n e d  u s i n g  M T S  a s s a y  k i t s  ( P r o m e g a ,  M a d i s o n ,  W I ) .
Real-time polymerase chain reaction (PCR)
For quantitative real-time PCR, whole lungs were homogen-
iz e d an d t he  t o ta l lu ng  mR N A  ex t ra ct s wa s pre pa re d us in g 
an RNeasy Mini Kit (Qiagen Korea Ltd., Seoul, Korea). Three 
micrograms of the RNA were then reverse transcribed using 
Moloney  murine  leukemia  virus  reverse  transcriptase  (Pro-
mega, Medison, WI, USA) was performed using the following 
primers  and  probes  from  Applied  Biosystems  (Foster  City, 
CA):  GAPDH  (TaqMan  Assay  Reagent:  4352339E),  IFN-γ 
(TaqMan  Assay  Reagent:  Mm  00801778  m1),  IL-4  (TaqMan 
Assay  Reagent:  Mm  00445259_m1),  MIP-1alpha  (TagMan 
Assay  Reagent  Mm  99999057_m1),  MCP-1  (TagMan  Assay 
Reagent; Mm 99999056_m1), IP-10 (TagMan Assay Reagent; 
Mm 99999072_m1) and RANTES (TagMan Assay Reagent; Mm 
01302427_m1).  The  results  for  each  cytokine  were  normal-
ized  with  respect  to  GAPDH  expression.
Statistics
Statistical significance was analyzed using the program Prism 
4.0.  Student's  t-tests  were  used  to  determine  the  p  value 
when comparing two groups. p values ＜0.05 were consid-
ered  significant.
RESULTS
The subsets of inflammatory cells recruited into the 
lungs are different between FcγR- deficient and B6 
m i c e  d u r i n g  S R - i n d u c e d  hypersensitivity pneumo-
nitis
To investigate whether FcγRs play a role in the development 
of  HP,  we  administrated  SR  antigen  intranasally  to  B6  and 
FcγR
−/− mice on three consecutive days. Seven days after 
the first SR antigen exposure, the immune cells in the lung 
tissues of B6 and FcγR
−/− mice were examined. As shown 
in  Fig.  1B,  there  was  no  significant  difference  in  total  cell 
numbers of BALF between B6 and FcγR
−/− mice in SR-in-
duced HP. However, the cellular composition of inflamma-
tory cells in BALF of FcγR
−/− mice differed from that of B6 
mice (Fig. 1A and C). The numbers of macrophages and neu-
trophils  were  markedly  reduced,  while  T,  B,  and  dendritic 
cells were more recruited into the lungs of FcγR
−/− mice 
than those in B6 mice. HP is characterized by a lymphocytic 
alveolitis showing an increase in both the percentage and ab-
solute number of CD8
＋ T cells in the BALF (25). Therefore, 
the percentages of CD4
＋ and CD8
＋ T cells in the BALF from 
B6  and  FcγR
−/−  mice  were  examined  during  SR-induced 
HP. The numbers of CD4
＋ and CD8
＋ T cells were increased 
in BALF of FcγR
−/− mice compared with B6 mice (Fig. 1C). 
However, the percentage of CD8
＋ T cells among gated lym-
phocytes  in  BALF  of  FcγR
−/− mice was similar to that of 
B6 mice in SR-induced HP, whereas the percentage of CD4
＋ 
T  cells  was  much  higher  than  that  of  B6  mice  (Fig.  1D). 
Therefore,  CD8：C D4  T c el l ra ti o w as r ed u ce d  i n B A LF  of 
FcγR
−/− mice compared to B6 mice during SR-induced HP. 
Combined, these findings suggested that FcγR-deficeint in-
nate immune cells such as neutrophils and macrophages less 
migrated into the lungs than those cells of B6 mice, whereas 
more T and B cells were recruited into the lungs of FcγR
−/− 
mice  compared  to  B6  mice  during  SR-induced  HP.
    To compare the phenotypes of the B6 and FcγR
−/− mice 
with  HP,  we  investigated  the  histological  alterations  in  the 
lungs 3 weeks after the first SR antigen exposure. SR antigen 
induced multifocal pulmonary lesions characterized with peri-Fcγ Receptors Modulate Murine Hypersensitivity Pneumonitis
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Figure 1. B6 and FcγR
−/− mice show different cellular composition of BALF during SR-induced HP. BALF cells were obtained from mice 7
days after the first inoculation with SR antigen and counted. The cellular subset was evaluated using flow cytometric analysis. (A) FSC and SSC
scatter diagrams of total BALF cells in B6 and FcγR
−/− mice (B, C) The numbers of immune cells in BALF were counted and (D) the percentages
of CD4
＋ and CD8
＋ T cells were determined among the gated lymphocytes in flow cytometric analysis. The results shown are representative
of three independent experiments and statistical analysis was performed using the program Prism 4.0 (n=3, N.S.: not significant, *p＜0.05, **p
＜0.01, B6 mice versus FcγR
−/− mice).
bronchial lymphocytic infiltration, alveolitis, interstitial fibrosis 
i n  B 6  m i c e  ( F i g .  2 A ) .  I n  p a r t i c u l a r ,  t h e  i n f i l t r a t i o n  o f  n e u -
trophils and macrophages in alveolar spaces and interstitium 
of B6 mice was prominent compared with FcγR
−/− mice. 
I n  c o n t r a s t ,  p e r i b r o n c h i a l  h y p e r p l a s i a  o f  l y m p h o i d  f o l l i c l e s  
was  more  frequently  found  in  FcγR
−/− m i c e  t h a n  i n  B 6  
mice. Consistent with histological alteration in these mice, the 
histological  scorings  of  the  pulmonary  lesions  revealed  sig-
nificant attenuation of HP in FcγR
−/− mice compared with 
B6  mice  (Fig.  2B).
FcγR-deficient mice show the reduced expression 
of chemokines and IFN-γ compared to B6 mice 
during SR- induced hypersensitivity  pneumonitis
Many studies have indicated that various cytokines and che-
mokines are important  in the pathogenesis of  inflammatory 
lung  diseases  (8,10,26,27).  Cytokines  and  chemokines  in-
duced  by  administration  of  SR  antigen  mediate  the  recruit-
ment of immune cells and induce differentiation of Th1 cells, 
resulting in granuloma formation. To evaluate cytokines and 
chemokines expression in FcγR
−/− and B6 mice after SR an-Fcγ Receptors Modulate Murine Hypersensitivity Pneumonitis
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Figure 2. Hypersensitivity pneumonitis is attenuated in FcγR
−/− mice
compared to B6 mice in terms of histological alteration. In B6 and 
FcγR
−/− mice, hypersensitivity pneumonitis was induced by 
inoculating SR antigen intranasally. These mice were sacrificed 3 
weeks after HP induction. (A) The lungs were removed from the B6 
and FcγR
−/− mice, and paraffin sections were stained with H&E. 
Original magnification, ×100 or ×400. The photographs are 
representative of the three mice in each group. (B) Inflammatory 
responses in the lungs of B6 and FcγR
−/− mice were graded. 0 (n=3, 
*p＜0.05, B6 mice versus FcγR
−/− mice).
tigen  administration,  we  measured  mRNAs  of  IFN-γ,  IL-4, 
IP-10,  Mip1α,  RANTES,  and  MCP-1  in  the  lungs.  The  ex-
pression of IP-10, Mip1α, RANTES, and MCP-1 was reduced 
in FcγR
−/−  mice  compared  to  B6  mice  (Fig.  3A). Among 
these chemokines, the production of IP-10 was significantly 
different between B6 and FcγR
−/− mice. Upon inoculation 
of SR-antigen, FcγR
−/− mice exhibited the low levels of IFN- 
γ, whereas the transcript level of IL-4 was significantly in-
creased (Fig. 3B). Therefore, FcγR
−/− mice show decreased 
chemokines expression and Th2-dominant immune responses 
during  SR-induced  HP.
FcγR-deficient mice do not affect SR-induced 
adaptive immune responses
The immunologic responses to SR antigen in SR-induced HP 
can be assessed by measuring SR-specific immune cell pro-
liferation, and IgG levels in sera and BALF of mice given SR 
antigen (2,28,29). To evaluate the immune responses against 
SR antigen, BALF and sera from B6 and FcγR
−/− mice ad-
ministered SR antigen three weeks after the first antigen ex-
posure  were  obtained.  FcγR
−/− m i c e  g i v e n  S R  a n t i g e n  
showed slightly higher serum SR-specific IgG levels (Fig. 4A), 
whereas B6 mice challenged with SR antigen showed slightly 
higher IgG production in BALF (Fig. 4B). However, we could 
not  find  statistically  significant  difference  in  the  IgG  levels 
both of sera and of BALF between B6 and FcγR
−/− mice. 
To evaluate SR-specific immune cell proliferation, splenocytes 
from B6 and FcγR
−/− mice were stimulated with SR antigen 
in vitro  24  h.  The proliferation  of immune  cells  against SR 
antigen showed no difference between SR-challenged B6 and 
FcγR
−/− mice (Fig. 4C). These results indicated that activat-
ing FcγRs do not play a critical role in modulation of SR-in-
duced  adaptive  immune  responses.
DISCUSSION
During the development of HP, the inhaled antigen enters the 
alveolar spaces, crosses the alveolar endothelium, and binds 
to circulating antibody leading to immune complexes deposi-
tion  within  the  lung  (30).  Moreover,  these  immune  com-
plexes activate various immune cells via engagement of IgG 
Fc receptors containing an activation motif (ITAM), resulting 
in  initiation  and  propagation  of  an  inflammatory  response 
(31). Therefore, it has been suggested that FcγR play a crit-
ical role in the development of HP. Consistent with this sug-
gestion,  our  experiments  demonstrated  that  FcγR
−/− m i c e 
exhibited an attenuated phenotype of HP in terms of histo-
logic alterations compared with B6 mice, indicating that acti-
vating FcγRs contribute to the development of SR-induced 
HP. The activating FcγRs (FcγRI, III, and IV) are usually 
expressed on innate cells such as monocytes, macrophages, 
d e n d r i t i c  c e l l s ,  w h e r e a s  B  c e l l s  e x p r e s s  i n h i b i t o r y  F cγRIIB 
and none of FcγRs is detected on T cells (17). Thus, this 
expression pattern of FcγR on immune cells enables us to 
hypothesize  that  innate  immune  cells  might  be  involved  in 
FcγR-mediated immune responses of SR-induced HP rather 
than adaptive immune cells. Consistent with this hypothesis, 
the cellular compositions of BALF were strikingly different be-Fcγ Receptors Modulate Murine Hypersensitivity Pneumonitis
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Figure 3. FcγR
−/− mice alter chemokines and cytokines expression in the lungs during SR-induced HP. The transcription of chemokines such
as IP-10, Mip-1α, RANTES and MCP-1 (A) and cytokines, IFN-γ, and IL-4 (B) were measured using real-time PCR in the lungs from B6 and 
FcγR
−/− mice 7 days after the first administration of SR antigen. All expression levels were normalized to GAPDH. The results shown are 




−/− and B6 mice in SR-induced HP. Macropha-
ges and neutrophils were significantly reduced in BALF of Fc
γR
−/− mice compared to B6 mice, whereas T and B lym-
phocytes were increased. These findings indicate that FcγRs 
contribute  to  activation  and  recruitment  of  macrophages  or 
neutrophils  via  immune  complexes,  resulting  in  attenuation 
of histopathology of lung parenchyma in FcγR
−/− mice dur-
ing SR-induced HP. HP has been considered to involve two 
pathologic mechanisms: immune complex-mediated immune 
response and T cell-mediated immune response (32). These 
mechanisms  occur  either  simultaneously  and/or  indepen-
dently at different stages of the disease. The former mecha-Fcγ Receptors Modulate Murine Hypersensitivity Pneumonitis
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Figure 4. FcγR
−/− mice show similar SR-specific proliferation of 
immune cells and production of IgG during SR-induced HP. HP was
induced by intranasal inoculation of SR antigen. (A, B) The lungs were
removed from the B6 and FcγR
−/− mice 3 weeks after induction of 
HP, and the amounts of SR-specific IgG in BALF and serum were 
measured 3 weeks after HP induction using ELISA. (C) Immune cell 
proliferation to SR antigen was evaluated by a MTS assay using spleen
cells 21 days after the first nasal inoculation with SR antigen. The 
results shown are representative of three independent experiments 
and statistical analysis was performed using the program Prism 4.0 
(n=3, N.S.: not significant,, B6 mice versus FcγR
−/− mice).
nism usually initiates and mediates the acute HP, while the 
latter mediates the subacute and chronic HP. Therefore, it is 
more likely that FcγR-mediated activation and recruitment of 
innate  immune  cells  might  be  an  early  event  of  HP  rather 
than  occur  at  chronic  phase  of  disease.
  I F N - γ produced by T cells and neutrophils in the lungs 
contributes to the development of murine HP, categorized as 
a Th1 disease (5,33). Moreover, IFN-γ-producing neutrophils 
contribute to granuloma formation in the absence of IFN-γ
-producing T cells during SR-induced HP (10). These findings 
indicate that innate immune cells more contribute to IFN-γ 
production  and  development  of  HP  than  adaptive  immune 
cells do. In our experiments, the subset analysis of BALF re-
vealed that neutrophils were remarkably reduced in BALF of 
FcγR
−/− mice during SR-induced HP, which led us to hy-
pothesize that small numbers of neutrohpils in the lungs of 
FcγR
−/− mice produce small amount of IFN-γ, resulting in 
the  marked  reduction  of  IFN-γ production  in  the  lungs. 
However, we did not detect statistically significant reduction 
of  IFN-γ production  in  the  lungs  of  FcγR
−/− m i c e  c o m-
pared to B6 mice. Here, there are several lines of evidences 
to explain this discrepancy in IFN-γ production of FcγR
−/− 
mice during SR-induced HP. First, in contrast to neutrophils, 
CD4
＋ T cells, known to be another main source of IFN-γ 
in the lungs during SR-induced HP, significantly increased in 
BALF of FcγR
−/− mice upon SR antigen inoculation. These 
findings suggest that IFN-γ produced by CD4
＋ T cells might 
c o m p e n s a t e  r e d u c e d  a m o u n t  o f  I F N - γ produced  by  neu-
trophils during SR-induced HP. Second, we recently reported 
that IL-4-producing NKT cells play a protective role in SR-in-
duced HP by suppressing IFN-γ-producing neutrophils (11). 
Moreover, NKT cells express an activating receptor FcγRIII 
that provides strong activating signals for activation of these 
cells (34-36). Our experiments in antibody-induced joint in-Fcγ Receptors Modulate Murine Hypersensitivity Pneumonitis
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flammation demonstrated that the engagement of FcγRIII via 
immune  complexes  activates  NKT  cells,  resulting  in  modu-
lation of joint inflammation (37). Thus, there is a possibility 
that signals via FcγRIII also contribute to activation of NKT 
cells during SR-induced HP, which suppresses IFN-γ-produc-
ing  neutrophils  in  the  lungs.  Based  on  this  possibility,  we 
postulate that loss of activating signals via FcγRIII on NKT 
cells in FcγR
−/− mice causes the reduction of suppressive 
effects  on  IFN-γ-producing  neutrophils,  resulting  in  en-
hancement of IFN-γ production by neutrophils during SR-in-
duced HP. Combined, it is suggested that increased number 
of IFN-γ-producing CD4
＋ and CD8
＋ T cells in the lungs and 
loss  of  NKT  cell-mediated  suppression  of  IFN-γ-producing 
neutrophils  in  FcγR
−/−  mice  compensate  reduced  IFN-γ 
production  by  FcγR-deficient  neurtophils.
    Considering clinical aspects of HP, the presence of serum 
precipitating  antibodies  or  cell-mediated  hypersensitivity 
against presumptive antigens may be helpful for the diagnosis 
of patients with HP (2,28,29). Moreover, in several studies us-
ing the SR-induced murine HP model, SR-spedific serum IgG 
or IL-2 production of BAL cells was measured to evaluate the 
adaptive immune responses in SR-induced HP (38,39). There-
fore, to examine adaptive immune responses, we measured 
the SR-specific immune cell proliferation and the IgG levels 
both in sera and BALF. In contrast to histological alteration 
and  cellular  composition  of  BALF,  there  was  no  difference 
in  adaptive  immune  responses  between  B6  and  FcγR
−/− 
mice upon SR-antigen exposure. However, our experiments 
demonstrated that the number of CD4
＋ and CD8
＋ T, and B 
cells in BALF of FcγR
−/− mice increased compared to that 
of B6 mice. These findings suggest that adaptive immune re-
sponses induced by T and B cells against SR antigen are not 
affected in FcγR
−/− mice although T and B cells more in-
filtrated  into  the  lungs  of  FcγR
−/− m i c e  c o m p a r e d  t o  B 6  
mice. Very recently, we reported that CD4
＋CD25
＋ regulatory 
T (Treg) cells attenuate SR-induced HP by suppressing IFN-γ- 
producing CD4
＋ and CD8
＋ T cells in the lungs via both di-
rect  cell-to-cell  contact  and  IL-10  dependent  manners  (40). 
Even  though  the  exact  number  and  function  of  Treg  cells 
needs to be determined in FcγR
−/− and B6 mice, it is hy-
pothesized that increased numbers or function of Treg cells 
upon SR angtigen challenge contributes to more suppression 
of CD4
＋ and CD8
＋ T cells in FcγR
−/− mice upon SR anti-
gen exposure, resulting in similar adaptive immune responses 
between  FcγR
−/−  and  B6  mice.
    Avoidance of the causative antigens and steroid treatment 
are  well-known  treatment  of  patients  with  HP.  However, 
some patients develop advanced pulmonary fibrosis despite 
of treatment (2). Therefore, alternative therapeutic modalities 
m u s t  b e  d e v e l o p e d .  H e r e ,  w e  p r o p o s e  a  t h e r a p e u t i c  a p -
proach using blockage of activating FcγRs based on our cur-
rent research (11). However, it is likely that the blockage of 
FcγRs might attenuate the protective function of FcγRIII-ex-
pressing NKT cells on HP, which provides adverse effects on 
the treatment of HP. Therefore, a comprehensive approach 
should be considered to optimize therapeutic effects on HP. 
    In summary, our results demonstrate that activating signals 
through Fcγ receptors play an important role in the develop-
m e nt  o f H P b y  pro v ok in g  in na te  im m un e  ce ll s t o m o bi liz e 
and  to  produce  cytokines  in  particular  Th1  inducing  cyto-
kines. These results provide new insights into the complex 
immunological mechanisms underlying HP, and lead to the 
development  of  more  effective  therapeutic  approaches  for 
HP.
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